Md. Motiar Rahman

Md. Motiar Rahman


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MRMd. Motiar Rahman
Md. Motiar Rahman
MAMst Gulshan Ara
Mst Gulshan Ara
AAAbdul Alim
Abdul Alim
SUSahab Uddin
Sahab Uddin
Agnieszka Barbara NajdaAgnieszka Barbara Najda
Agnieszka Barbara Najda
Mohamed Abdel-DaimMohamed Abdel-Daim
Mohamed Abdel-Daim
Mesoporous carbon is a promising material having multiple applications. It can act as a catalytic support and can be used in energy storage devices. Moreover, mesoporous carbon controls body’s oral drug delivery system and adsorb poisonous metal from water and various other molecules from an aqueous solution. The accuracy and improved activity of the carbon materials depend on some parameters. The recent breakthrough in the synthesis of mesoporous carbon, with high surface area, large pore-volume, and good thermostability, improves its activity manifold in performing functions. Considering the promising application of mesoporous carbon, it should be broadly illustrated in the literature. This review summarizes the potential application of mesoporous carbon in many scientific disciplines. Moreover, the outlook for further improvement of mesoporous carbon has been demonstrated in detail. Hopefully, it would act as a reference guidebook for researchers about the putative application of mesoporous carbon in multidimensional fields.

11 March 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MRMd. Motiar Rahman
Md. Motiar Rahman
NZnan zhou
nan zhou
JHJIANDONG HUANG
JIANDONG HUANG
The mRNA-based vaccine approach is a promising alternative to traditional vaccines due to its ability for prompt development, high potency, and potential for secure administration and low-cost production. Nonetheless, the application has still been limited by the instability as well as the ineffective delivery of mRNA in vivo. Current technological improvements have now mostly overcome these concerns, and manifold mRNA vaccine plans against various forms of malignancies and infectious ailments have reported inspiring outcomes in both humans and animal models. This article summarizes recent mRNA-based vaccine developments, advances of in vivo mRNA deliveries, reflects challenges and safety concerns, and future perspectives, in developing the mRNA vaccine platform for extensive therapeutic use.